Medical Device Innovation Consortium (MDIC) Announces the Appointment of Andrew Fish, JD, as President and Chief Executive Officer (CEO) | Company

ByLance T. Lee

Jun 8, 2022


The Medical Device Innovation Consortium (MDIC) today announced the appointment of Andrew Fish, JD, as President and Chief Executive Officer, effective July 20, 2022. Mr. Fish succeeds Pamela Goldberg, who resigns after leading the organization for four years.

Mr. Fish joins MDIC following his last term as Executive Director of the Center for Digital Health and Head of Industry Initiatives at AdvaMed, where he significantly expanded the membership and scope of the association’s health work. digital while supporting the Centre’s executive leadership group. Previously, Mr. Fish served as the first Executive Director of AdvaMedDx, AdvaMed’s corporate division focused on in vitro diagnostics, and subsequently as AdvaMed’s Chief Strategy Officer, overseeing policy departments global and national association and providing thought leadership on the rapidly changing role of medical technology in all healthcare delivery settings. Mr. Fish has demonstrated consistent success in developing effective public policy and achieving advocacy goals in many areas of health care regulation and delivery.

“Over the past several months, the Board has conducted an extensive search for a CEO with significant experience in building and leading cross-functional teams and a passion for medical device innovation. With his exceptional track record of leading and growing organizations with a commitment to advancing innovative patient care, Andrew is the ideal leader for MDIC as we continue to collaborate with our partners to advance science and enable the transformational medical technology to shape the future,” said MDIC. Chairman of the Board Jijo James MD, Medical Director, MedTech and External Innovation at Johnson & Johnson.

“CDRH congratulates Andy Fish on his appointment as the new President and CEO of MDIC. We look forward to working with Andy and continuing our collaboration and partnership with MDIC to support medical device safety and innovation for the benefit of patient health,” said Jeffrey Shuren MD, JD, Director, Center for Devices and Radiological Health (CDRH), FDA.

MDIC, through its public-private partnership between government and regulatory agencies, non-profit organizations and the medical device industry, aims to advance regulatory science and bring innovative technologies to patients. MDIC coordinates the development of methods, tools and resources used in medical device lifecycle management to improve patient access to advanced medical technologies.

“With over 20 years of industry experience, Andrew has the knowledge, expertise and commitment to continue to build on the success of MDIC that Pamela Goldberg helped establish. Among other accomplishments, Pamela helped launch the Health Economics and Patient Value initiative to increase the use of real-world evidence in healthcare decision-making. We are grateful for his leadership over the past four years,” said James.

“Andy’s service at AdvaMed over the past 12 years has prepared him very well to lead MDIC,” said AdvaMed President and CEO Scott Whitaker. “While we will miss Andy, we are happy to know that he is not going overboard – MDIC has always been a great partner to AdvaMed, given our shared mission to improve patient care, and we are looking forward to continuing the good work with MDIC under his leadership.”

In accepting the role of CEO, Mr. Fish said, “I am grateful to have the opportunity to lead MDIC as President and CEO. I look forward to bringing medical device and diagnostics stakeholders together and leveraging our collective expertise, resources and data to create new methods, tools, approaches and standards that will help develop medical technologies that are safe and effective for patients around the world.

About the Medical Devices Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created for the sole purpose of advancing the regulatory science of medical devices throughout the entire product lifecycle. MDIC’s mission is to promote public health through science and technology and to build trust among stakeholders. MDIC works in the pre-competitive space to facilitate the development of methods, tools and approaches that improve the understanding and evaluation of product safety, quality and efficacy. Its initiatives improve product safety and patient access to advanced medical technologies while reducing costs and time to market. For more information, visit

See the source version on

CONTACT: Gregory Bologna, MDIC

AVP, Marketing and Communications

[email protected]



SOURCE: Medical Devices Innovation Consortium

Copyright BusinessWire 2022.

PUBLISHED: 06/08/2022 17:01 / DISK: 06/08/2022 17:02

Source link